Your browser doesn't support javascript.
Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria.
Shanshal, Mohammed.
  • Shanshal M; Department of Dermatology and Venereology, Specialist Dermatologist at Baghdad Teaching Hospital, Baghdad, Iraq.
J Dermatolog Treat ; 33(2): 1140-1141, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-639607
ABSTRACT
Dermatologists around the world are still doing their best to report more cutaneous manifestations of the emerging COVID-19 infection. New-onset acute or relapsing chronic urticaria may result from the body's overreacting inflammatory response to infection. The cytokine storm hits different organs in the body, including the skin, leading to activation and degranulation of mast cells with resultant urticaria. Low-dose systemic steroids combined with antihistamines can combat the COVID-19 inflammatory insult and play a role in the control of COVID-19 related severe urticarial attack.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / Chronic Urticaria / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: J Dermatolog Treat Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: 09546634.2020.1795062

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / Chronic Urticaria / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: J Dermatolog Treat Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: 09546634.2020.1795062